Which patient is going to benefit from surgical cytoreduction with intraperitoneal chemotherapy (for manifest peritoneal metastases)?

1. Elias D, Mariani A, Cloutier A, Blot F, Goéré D, Dumont F et al. Modified selection criteria for complete cytoreductive surgery plus HIPEC based on peritoneal cancer index and small bowel involvement for peritoneal carcinomatosis of colorectal origin. European Journal of Surgical Oncology (EJSO). 2014;40(11):1467-147310.1016/j.ejso.2014.06.006Search in Google Scholar

2. Bang Y, Van Cutsem E, Feyereislova A, Chung H, Shen L, Sawaki A et al. Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial. The Lancet. 2010;376(9742):687-697.10.1016/S0140-6736(10)61121-XSearch in Google Scholar

3. Al-Batran S, Homann N, Pauligk C, Illerhaus G, Martens U, Stoehlmacher J et al. Effect of Neoadjuvant Chemotherapy Followed by Surgical Resection on Survival in Patients With Limited Metastatic Gastric or Gastroesophageal Junction Cancer. JAMA Oncology. 2017;3(9):1237.10.1001/jamaoncol.2017.0515582428728448662Search in Google Scholar

4. Sugarbaker P. Peritonectomy Procedures. Annals of Surgery. 1995;221(1):29-42.10.1097/00000658-199501000-0000412344927826158Search in Google Scholar

5. Piso P, Leebmann H, März L, Mayr M. Zytoreduktive Chirurgie für maligne Tumoren des Peritoneums. Der Chirurg. 2014;86(1):38-46.10.1007/s00104-014-2724-z24722868Search in Google Scholar

6. Jacquet, P., Sugarbaker, P. H. Clinical research methodologies in diagnosis and staging of patients with peritoneal carcinomatosis. Cancer treatment and research. 1996;82, 359-374.Search in Google Scholar

7. Chua T, Yan T, Saxena A, Morris D. Should the Treatment of Peritoneal Carcinomatosis by Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy Still be Regarded as a Highly Morbid Procedure?. Annals of Surgery. 2009;249(6):900-907.10.1097/SLA.0b013e3181a45d8619474692Search in Google Scholar

8. Chia C, You B, Decullier E, Vaudoyer D, Lorimier G, Abboud K et al. Patients with Peritoneal Carcinomatosis from Gastric Cancer Treated with Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy: Is Cure a Possibility?. Annals of Surgical Oncology. 2016;23(6):1971-1979.10.1245/s10434-015-5081-326753751Search in Google Scholar

9. Yang X, Huang C, Suo T, Mei L, Yang G, Cheng F et al. Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy Improves Survival of Patients with Peritoneal Carcinomatosis from Gastric Cancer: Final Results of a Phase III Randomized Clinical Trial. Annals of Surgical Oncology. 2011;18(6):1575-1581.10.1245/s10434-011-1631-5308787521431408Open DOISearch in Google Scholar

10. Rudloff U, Langan R, Mullinax J, Beane J, Steinberg S, Beresnev T et al. Impact of maximal cytoreductive surgery plus regional heated intraperitoneal chemotherapy (HIPEC) on outcome of patients with peritoneal carcinomatosis of gastric origin: Results of the GYMSSA trial. Journal of Surgical Oncology. 2014;110(3):275-284.10.1002/jso.23633630103125042700Search in Google Scholar

11. Canbay E, Mizumoto A, Ichinose M, Ishibashi H, Sako S, Hirano M et al. Outcome Data of Patients with Peritoneal Carcinomatosis from Gastric Origin Treated by a Strategy of Bidirectional Chemotherapy Prior to Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy in a Single Specialized Center in Japan. Annals of Surgical Oncology. 2013;21(4):1147-1152.10.1245/s10434-013-3443-224356799Search in Google Scholar

12. Boerner T, Graichen A, Jeiter T, Zemann F, Renner P, März L et al. CRS-HIPEC Prolongs Survival but is Not Curative for Patients with Peritoneal Carcinomatosis of Gastric Cancer. Annals of Surgical Oncology. 2016;23(12):3972-3977.10.1245/s10434-016-5306-027313067Search in Google Scholar

13. Desiderio J, Chao J, Melstrom L, Warner S, Tozzi F, Fong Y et al. The 30-year experience—A meta-analysis of randomised and highquality non-randomised studies of hyperthermic intraperitoneal chemotherapy in the treatment of gastric cancer. European Journal of Cancer. 2017;79:1-14.10.1016/j.ejca.2017.03.030556841928456089Open DOISearch in Google Scholar